Proiektuen kudeaketa unitatea
/es/servicios/unidades-de-apoyo/gestion-de-investigacion-proyectos
| 01 | ||||||
| 02 | 03 | 04 | 05 | 06 | 07 | 08 |
| 09 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | |
24
01
2023
Deialdiak
5 emaitzak
10/02/2026
Añadir al calendario
2026-02-10 01:00:00
2026-04-16 02:00:00
Horizonte Europa - Programa de trabajo clúster salud 2026
La Comisión Europea ha publicado las convocatorias del Clúster 1 en el ámbito de la salud de Horizonte Europa. El programa de trabajo 2026-2027 consta de un total de 38 topics (temáticas) para la financiación de proyectos de investigación e innovación, además de acciones de coordinación y apoyo, en diversas áreas de la salud.
La convocatoria del 2026 incluye 18 topics que se agrupan en seis Destinations (Destinos) diferentes:
Consulta el Programa de Trabajo 2026-2027 del Clúster Salud de Horizonte Europa aquí.
Destino 1 - Mantenerse saludable en una sociedad que cambia rápidamente
Topics:
HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people.
HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences.
Destino 2 - Vivir y trabajar en un entorno que promueva la salud
Topics:
HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health.
HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems.
HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research.
Destino 3 - Abordar las enfermedades y reducir la carga de morbilidad
Topics:
HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults.
HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions.
HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential.
HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD).
HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways.
HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health.
Destino 4 - Garantizar el acceso equitativo a una atención sanitaria innovadora, sostenible y de alta calidad
Topics:
HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches.
HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems.
Destino 5 - Desarrollar y utilizar nuevas herramientas, tecnologías y soluciones digitales para una sociedad saludable
Topics:
HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing.
HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging Eufunded collaborative research in regenerative medicine.
HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices.
HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs).
Destino 6 - Mantener una industria sanitaria de la UE innovadora, sostenible y competitiva
Topics:
HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies.
Aprovecha para informarte sobre estas convocatorias, de la mano de expertos, en la jornada informativa organizada por la Comisión Europea el 10 de febrero 2026. Puedes consultar el programa de la jornada en el siguiente link.
*/
*/
*/
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public
10/02/2026
Añadir al calendario
2026-02-10 01:00:00
2026-09-15 02:00:00
Horizonte Europea - Programa de trabajo Misiones 2026-2027
La Comisión Europea ha publicado el Programa de Trabajo de las Misiones 2026-2027. El programa incluye convocatorias en diferentes ámbitos prioritarios para la Comisión, entre los que se encuentra Misión Cáncer.
El objetivo de Misión Cáncer es mejorar la vida de más de 3 millones de personas para 2030, mediante la prevención, la cura y, para quienes están afectados por el cáncer, incluyendo a sus familias, vivir más tiempo y con mejor calidad de vida. Para ello se financiarán proyectos de investigación e innovación, además de acciones de coordinación y apoyo, a través de diferentes topics:
Convocatoria 2026 (Deadline: 15 de Septiembre 2026):
HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research.
HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease.
HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers.
HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care.
HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC).
HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine.
HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients.
Convocatoria 2027 (Deadline: 21 de Septiembre 2027):
HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment.
HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers.
HORIZON-MISS-2027-02-CANCER-03: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes.
HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research.
HORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines.
HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies.
Consulta las bases de las convocatorias aquí.
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public
08/01/2026
Añadir al calendario
2026-01-08 01:00:00
2026-02-25 01:00:00
La Caixa HealthCare Research 2026
La Fundación ”la Caixa” lanza la primera edición de la convocatoria para proyectos de investigación en promoción de la salud. El objetivo de esta convocatoria es identificar investigaciones que impulsen el diseño y la evaluación de intervenciones sanitarias en la promoción de la salud y la prevención de enfermedades.
Las propuestas presentadas deben:
Adoptar un enfoque aplicado a problemas de salud relevantes
Emplear metodologías rigurosas y validadas
Integrar, cuando sea pertinente, perspectivas de múltiples profesionales y disciplinas de investigación
Mostrar una vía clara hacia la escalabilidad
Las áreas de interés de la convocatoria incluyen, entre otras: salud mental, salud de la mujer, salud infantil y adolescente, nutrición y estilos de vida saludables, envejecimiento saludable y manejo de la cronicidad.
Las propuestas han de pertenecer a alguna de estas tipologías:
Estudios piloto: estudios preliminares a pequeña escala que evalúen la viabilidad de una intervención mayor. Pueden recibir ayudas de un máximo de 80.000 €. Su duración máxima será de 2 años.
Evaluaciones retrospectivas: propuestas que evalúan la efectividad y el impacto de intervenciones sanitarias existentes. Pueden recibir ayudas de un máximo de 150.000 €. Su duración máxima será de 2 años.
Nuevas intervenciones: propuestas que desarrollan y evalúan nuevas intervenciones sanitarias. Pueden recibir ayudas de un máximo de 300.000 €. Su duración máxima será de 3 años.
Los tres tipos de propuestas pueden llevarse a cabo de forma individual (una sola organización de investigación participante) o en consorcio (una organización de investigación y hasta cuatro organizaciones colaboradoras).
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public
25/11/2025
Añadir al calendario
2025-11-25 01:00:00
2026-02-10 01:00:00
EP PerMed -Joint Transnational Call for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
The European Partnership for Personalised Medicine, EP PerMed (supported by the European Union under Horizon Europe, Grant Agreement N° 101137129) has launched the joint transnational call 2026 (JTC2026) “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases” (acro-nym: CARMEN2026), co-funded by the European Union, to fund multinational, innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe and beyond in this field. The available budget for this call is 38 Mio. € (approx.).
Main Objective: Fund research in human health focusing on personalised medicine strategies for:
Cardiovascular diseases
Metabolic diseases
Kidney diseases
(Projects may address one disease or combinations of these.)
Eligible Research Topics Projects should address one or more of the following:
Personalised Therapeutic Approaches: Develop and validate innovative treatments using relevant pre-clinical models (e.g., organoids, organs-on-chips, disease-specific animal models, in silico models).
Treatment Monitoring: Identify and validate molecular markers or advanced technologies to monitor treatment response, optimise dosage, and assess adverse effects.
Risk Prediction and Prevention: Identify and validate stratifying markers or diagnostic tools for early risk prediction and prevention of disease progression or comorbidities.
Collaboration Requirements:
Interdisciplinary research: Include fields such as bioinformatics, health economics, ELSA (ethical, legal, social aspects), and implementation research.
Cross-sector collaboration: Engage private sector (SMEs, industry), regulatory agencies, and patient organisations.
Participatory research: Ensure active involvement of patients or citizens.
Recommended Research Approaches Projects are encouraged to integrate:
Multi-omics data (genomics, proteomics, metabolomics, etc.) linked to treatment outcomes.
Cutting-edge technologies: AI/ML, next-generation imaging, digital health tools.
Patient-related information: Medication, compliance, adverse effects, patient-reported outcomes.
Additional factors: Sex/gender, age, environment, lifestyle, nutrition.
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public
05/11/2025
Añadir al calendario
2025-11-05 01:00:00
2026-10-28 01:00:00
EIC Work Programme 2026 - Pathfinder
The overall objective of the EIC Pathfinder for advanced research is to develop the scientific basis to underpin breakthrough technologies. It provides support for the earliest stages of scientific, technological or deep tech research and development. Pathfinder projects aim to build on new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities by realising innovative technological solutions through:
EIC Pathfinder Open, open to support projects in any field of science, technology or application without predefined thematic priorities.
Deadline 12 May 2026, 17:00 Brussels time.
EIC Pathfinder Challenges, to support coherent portfolios of projects within predefined thematic areas with the aim to achieve specific objectives for each Challenge.
Topics:
Advanced Materials for Miniaturised Energy Harvesting Systems.
Biotechnology for Healthy Ageing.
DeepRAP: Deep Reasoning, Abstraction & Planning for trustworthy Cognitive AI Systems.
Deadline 28 October 2026, 17:00 Brussels time.
Grants up to EUR 4 million. Higher amounts if duly justified. Funding rate: 100% of eligible costs (lump sum).
Projects to achieve the proof of principle and validate the scientific basis of breakthrough technologies (starting from early TRLs aiming at achieving TRL3 or 4).
Location
Navarrabiomed
info@navarrabiomed
Europe/Madrid
public